Results 111 to 120 of about 424,455 (156)
High throughput screening on a low budget [PDF]
New assay technologies have combined with advances in automation, miniaturization, and affordable computing power to put small molecule drug discovery within reach of biotechnology ...
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Network Medicine and High Throughput Screening
Current Drug Discovery Technologies, 2013A new paradigm is emerging in modern drug discovery. It is a fusion of traditional and modern medicine, phenotypic and targeted drug discovery, or systems and reductionist thinking. This is exemplified by using a combination of network medicine and high throughput screening. It blends the use of physiologically relevant biological systems with the high
Robert E. Smith+2 more
openaire +2 more sources
2014
Ion channels are a class of proteins that are attractive human, animal, and crop health targets. Ion channels can be considered high-gain (physiologically speaking), high-reward (therapeutic benefit) and high technology (difficult assay development) drug targets.
Sabine Schaertl+2 more
openaire +2 more sources
Ion channels are a class of proteins that are attractive human, animal, and crop health targets. Ion channels can be considered high-gain (physiologically speaking), high-reward (therapeutic benefit) and high technology (difficult assay development) drug targets.
Sabine Schaertl+2 more
openaire +2 more sources
High-throughput screening technologies
2003In the past 5 years the world of high-throughput screening (HTS), which targets lead discovery for both pharmaceutical and agrochemical applications, is in a highly rapid developmental stage. Today, restructuring the drug discovery programs to develop highest performance is a key issue of pharmaceutical companies.
openaire +3 more sources
High-throughput screening brings in the crops
Drug Discovery Today, 2000Screening is the acknowledgement of ignorance. Such a provocative statement might not amuse our community and, in fact, an incredible quantity of knowledge does go into each screen. However, from a structural point of view, screening is where serendipity meets prediction.
openaire +3 more sources
Practical high throughput screening
1997During the first half of the century, there was virtually an exclusive reliance on animal testing as the primary model for drug discovery and development. New chemical entities were administered to rodents in the primary screen assay, and the appropriate responses were monitored for indications of therapeutic potential.
Alex Harris, Melvin Reichman
openaire +2 more sources
High Throughput Screening of Allergy
2015Allergen avoidance and specific immunotherapy that are based on an accurate diagnosis of allergy have proven to be helpful for the prevention and treatment of allergic diseases. Detection of specific IgE against different allergens in serum or plasma can be used as an important criterion for allergy diagnosis.
Ailin Tao, Junyan Zhang
openaire +2 more sources
Whither high-throughput screening?
Drug Discovery Today, 2000Abstract ‘…today’s HTS will become the fulcrum that fully leverages genomics in drug discovery’
openaire +2 more sources
Overview on High‐Throughput Screening
Current Protocols in Pharmacology, 2003AbstractThe known effects of drugs from a variety of pharmacological/therapeutic classes on the respiratory system, the life‐threatening consequences of respiratory dysfunction, and world‐wide regulatory safety guidelines all support the need for conducting respiratory evaluations in safety pharmacology. This unit provides an overview of the functional
openaire +2 more sources
New technologies for high-throughput screening
Current Opinion in Chemical Biology, 1997To screen efficiently the millions of compounds that are synthesized using combinatorial and automated methods, dramatically improved assay technologies are currently needed. In 96-well microtiter plates, nonradioactive techniques (primarily fluorimetric) and cell-based functional methods have moved to the cutting edge, while clever assays that extract
Jonathan J. Burbaum, Nolan H. Sigal
openaire +3 more sources